semaglutide/tirzepatide Addressing the Weight Loss Injectable Shortage: Exploring Compounded Semaglutide and Tirzepatide – Skippack Pharmacy Semaglutide, tirzepatide recommended as first-line
Description
In a move to contain claims costs, many insurers no longer cover GLP-1 drugs for weight loss only, instead limiting access to patients with a diagnosis of diabetes
It's also available through telehealth platforms and the manufacturer's direct pharmacy program, NovoCare
These are chemically modified salt forms that are distinct from the active ingredient in Ozempic or Wegovy, and their safety or effectiveness in humans has not been established
Nat Commun 2017
